Literature DB >> 34244677

Structure and function of retroviral integrase.

Goedele N Maertens1, Alan N Engelman2,3, Peter Cherepanov4,5.   

Abstract

A hallmark of retroviral replication is establishment of the proviral state, wherein a DNA copy of the viral RNA genome is stably incorporated into a host cell chromosome. Integrase is the viral enzyme responsible for the catalytic steps involved in this process, and integrase strand transfer inhibitors are widely used to treat people living with HIV. Over the past decade, a series of X-ray crystallography and cryogenic electron microscopy studies have revealed the structural basis of retroviral DNA integration. A variable number of integrase molecules congregate on viral DNA ends to assemble a conserved intasome core machine that facilitates integration. The structures additionally informed on the modes of integrase inhibitor action and the means by which HIV acquires drug resistance. Recent years have witnessed the development of allosteric integrase inhibitors, a highly promising class of small molecules that antagonize viral morphogenesis. In this Review, we explore recent insights into the organization and mechanism of the retroviral integration machinery and highlight open questions as well as new directions in the field.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34244677      PMCID: PMC8671357          DOI: 10.1038/s41579-021-00586-9

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  183 in total

1.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.

Authors:  T Jacks; M D Power; F R Masiarz; P A Luciw; P J Barr; H E Varmus
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

2.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

3.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

4.  The discovery of HTLV-1, the first pathogenic human retrovirus.

Authors:  John M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

5.  Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS).

Authors:  R C Gallo; P S Sarin; E P Gelmann; M Robert-Guroff; E Richardson; V S Kalyanaraman; D Mann; G D Sidhu; R E Stahl; S Zolla-Pazner; J Leibowitch; M Popovic
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

6.  Virus-coded origin of a 32,000-dalton protein from avian retrovirus cores: structural relatedness of p32 and the beta polypeptide of the avian retrovirus DNA polymerase.

Authors:  R D Schiff; D P Grandgenett
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis.

Authors:  Lars-Anders Carlson; John A G Briggs; Bärbel Glass; James D Riches; Martha N Simon; Marc C Johnson; Barbara Müller; Kay Grünewald; Hans-Georg Kräusslich
Journal:  Cell Host Microbe       Date:  2008-12-11       Impact factor: 21.023

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  HIV-1 capsid is involved in post-nuclear entry steps.

Authors:  Nan-Yu Chen; Lihong Zhou; Paul J Gane; Silvana Opp; Neil J Ball; Giuseppe Nicastro; Madeleine Zufferey; Cindy Buffone; Jeremy Luban; David Selwood; Felipe Diaz-Griffero; Ian Taylor; Ariberto Fassati
Journal:  Retrovirology       Date:  2016-04-23       Impact factor: 4.602

View more
  9 in total

1.  HIV-1 Preintegration Complex Preferentially Integrates the Viral DNA into Nucleosomes Containing Trimethylated Histone 3-Lysine 36 Modification and Flanking Linker DNA.

Authors:  Nicklas Sapp; Nathaniel Burge; Khan Cox; Prem Prakash; Muthukumar Balasubramaniam; Santosh Thapa; Devin Christensen; Min Li; Jared Linderberger; Mamuka Kvaratskhelia; Jui Pandhare; Robert Craigie; Michael G Poirier; Chandravanu Dash
Journal:  J Virol       Date:  2022-09-12       Impact factor: 6.549

2.  Cabotegravir, the Long-Acting Integrase Strand Transfer Inhibitor, Potently Inhibits Human T-Cell Lymphotropic Virus Type 1 Transmission in vitro.

Authors:  Bethany S Schneiderman; Michal S Barski; Goedele N Maertens
Journal:  Front Med (Lausanne)       Date:  2022-04-25

Review 3.  Multimodal Functionalities of HIV-1 Integrase.

Authors:  Alan N Engelman; Mamuka Kvaratskhelia
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

4.  Multivalent interactions essential for lentiviral integrase function.

Authors:  Allison Ballandras-Colas; Vidya Chivukula; Dominika T Gruszka; Zelin Shan; Parmit K Singh; Valerie E Pye; Rebecca K McLean; Gregory J Bedwell; Wen Li; Andrea Nans; Nicola J Cook; Hind J Fadel; Eric M Poeschla; David J Griffiths; Javier Vargas; Ian A Taylor; Dmitry Lyumkis; Hasan Yardimci; Alan N Engelman; Peter Cherepanov
Journal:  Nat Commun       Date:  2022-05-03       Impact factor: 17.694

Review 5.  The C-Terminal Domain of HIV-1 Integrase: A Swiss Army Knife for the Virus?

Authors:  Cecilia Rocchi; Patrice Gouet; Vincent Parissi; Francesca Fiorini
Journal:  Viruses       Date:  2022-06-27       Impact factor: 5.818

6.  Integrase deficient lentiviral vector: prospects for safe clinical applications.

Authors:  Chee-Hong Takahiro Yew; Narmatha Gurumoorthy; Fazlina Nordin; Gee Jun Tye; Wan Safwani Wan Kamarul Zaman; Jun Jie Tan; Min Hwei Ng
Journal:  PeerJ       Date:  2022-08-12       Impact factor: 3.061

7.  Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones.

Authors:  Otávio Augusto Chaves; Natalia Fintelman-Rodrigues; Xuanting Wang; Carolina Q Sacramento; Jairo R Temerozo; André C Ferreira; Mayara Mattos; Filipe Pereira-Dutra; Patrícia T Bozza; Hugo Caire Castro-Faria-Neto; James J Russo; Jingyue Ju; Thiago Moreno L Souza
Journal:  Viruses       Date:  2022-06-30       Impact factor: 5.818

8.  B-to-A transition in target DNA during retroviral integration.

Authors:  Ilona K Jóźwik; Wen Li; Da-Wei Zhang; Doris Wong; Julia Grawenhoff; Allison Ballandras-Colas; Sriram Aiyer; Peter Cherepanov; Alan N Engelman; Dmitry Lyumkis
Journal:  Nucleic Acids Res       Date:  2022-08-10       Impact factor: 19.160

Review 9.  Clonal Expansion of Infected CD4+ T Cells in People Living with HIV.

Authors:  John M Coffin; Stephen H Hughes
Journal:  Viruses       Date:  2021-10-15       Impact factor: 5.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.